Where does Jerel Davis work?

Jerel Davis is Managing Director at Versant Ventures and Board director at Firefly Bio, Inc. and Board director at Santa Ana Bio and Board director at Rayze Bio.

What does Jerel Davis invest in?

Jerel Davis invests in Biotech, Healthtech, Medical Devices.

What check size does Jerel Davis write?

Jerel Davis typically writes checks of $100K – $5M.

What boards does Jerel Davis sit on?

Jerel Davis holds tracked board seats at Chinook Therapeutics U.S, Firefly Bio, Inc., Graphite Bio, Inc., Mistral Therapeutics, Turnstone Biologics, Ventus Therapeutics.

What companies has Jerel Davis invested in?

Investments tracked here include Borealisbio, Chinook Therapeutics, Firefly Bio, Inc., Graphite Bio, Laguna Pharmaceuticals, Rayze Bio, Santa Ana Bio, Tentarix Biotherapeutics, Turnstone Biologics, Ventus Therapeutics.

Where did Jerel Davis go to school?

Jerel Davis studied at Stanford University (PhD, Population genetics and genomics); Pepperdine University (BS, Mathematics and Biology).

Jerel Davis

Investor

Managing Director at Versant Ventures · Board director at Firefly Bio, Inc. · Board director at Santa Ana Bio · Board director at Rayze Bio

Vancouver, BC

Writes $100K – $5M checks · typically $1.5M

Find your path to Jerel

1,782 people in our graph share verified history with Jerel — schools, employers, funds. One of them is your warm intro.

Laura BuhlerunlockedJerel: together at McKinsey & Company (2009–2011)

×6Jerel: together at Stanford University

×4Jerel: together at McKinsey & Company

Jerel: together at Ventus Therapeutics

About

Jerel Davis is a PhD-trained life scientist and Vancouver-based investor who builds biotechs from scratch via pharma partnerships—co-founding BlueRock with Bayer ($225M) and designing ventures with acquirers in mind.

Contact· self-published, not guessed

j•••@versantventures.comreveal

Invests in

BiotechHealthtechMedical Devices

Board director at Firefly Bio, Inc.

Intro paths

→

In turn, Jerel can intro founders to Firefly Bio, Inc.'s investors below.

Firefly Bio, Inc.'s investors · 3

Decheng CapitalMenlo Park · since 2024 MPM BioImpactBoston · $1M – $15M checks · since 2024 Versant VenturesSan Francisco · $250K – $5M checks · since 2023

Board director at Santa Ana Bio

Intro paths

→

In turn, Jerel can intro founders to Santa Ana Bio's investors below.

Santa Ana Bio's investors · 5

Access BiotechnologyNew York City Andreessen HorowitzMenlo Park · $500K – $50M checks GV (Google Ventures)Mountain View · $250K – $50M checks · since 2023 Versant Venture CapitalSan Francisco · since 2023 Versant VenturesSan Francisco · $250K – $5M checks · since 2023

Co-founders at Santa Ana Bio

Peter EmtageFounder & CEO

Alexander RudenskyScientific Founder

Richard FlavellScientific Founder

Graham LordScientific Founder

Ansuman SatpathyScientific Founder

Board director at Rayze Bio

Intro paths

→

In turn, Jerel can intro founders to Rayze Bio's investors below.

Rayze Bio's investors · 8

Samsara BioCapitalPalo Alto · since 2020 Scion Life SciencesNew York · $1K – $60M checks Sofinnova VenturesMenlo Park · $100K – $15M checks · since 2022 TCG CrossoverPalo Alto venBio Global StrategicSan Francisco · since 2022 venBio PartnersSan Francisco · since 2020 Versant VenturesSan Francisco · $250K – $5M checks · since 2020 Vivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Rayze Bio

Ken SongExecutive Officer, Director

Experience

Versant VenturesManaging Directorcurrent2011 — presentVancouver
Ventus TherapeuticsBoard Chaircurrent2020 — present
Borealis Biosciences, Inc.Board Chaircurrent2024 — presentVancover
Santa Ana BioBoard Membercurrent2022 — present
Fable TherapeuticsBoard Chaircurrent2023 — present
Firefly BiologicsBoard Membercurrent2022 — presentSouth San Francisco, California, United States
Tentarix Biotherapeutics, Inc.Board Membercurrent2020 — present
Kolm TherapeuticsBoard Member2022 — 2025Connecticut, United States
Nested TherapeuticsBoard Member2022 — 2023
Chinook Therapeutics, Inc.Board Member2019 — 2023
RayzeBioBoard Member2020 — 2023
Repare TherapeuticsBoard Member2017 — 2023
Northern BiologicsBoard Member2015 — 2020Toronto, Ontario, Canada
BlueRock TherapeuticsBoard Member2016 — 2019
Inception 4, Inc.Board Member2013 — 2018
Inception 5 IncBoard Member2014 — 2018
CRISPR TherapeuticsBoard Observer2014 — 2016
Quanticel PharmaceuticalsBoard Observer2011 — 2015
McKinsey & CompanyAssociate Principal2006 — 2011San Francisco
Stanford UniversityPostdoc2005 — 2006
AmgenResearch Associate1999 — 2000

Skills & more

Biotechnology53Pharmaceutical Industry29Medical Devices14R&D14Strategy34Pricing2Molecular Diagnostics3Lifesciences5Corporate Development5Venture Capital15Due Diligence5Business Strategy10

+12 more

Start-upsMergersEntrepreneurshipLife SciencesProduct ManagementStrategic PlanningFinancial ModelingCommercializationBusiness DevelopmentResearch and Development (R&D)Mergers & AcquisitionsMolecular Genetics

From Jerel's professional profile.

Deals · 6

Firefly Bio, Inc.Board seat

via Versant Ventures · filed Mar 2024 · $72M raise

Ventus TherapeuticsBoard seat

via Versant Ventures · filed Feb 2022 · $140M raise

Graphite Bio, Inc.Board seat

via Versant Ventures · filed Mar 2021 · $150.7M raise

Chinook Therapeutics U.SBoard seat

via Versant Ventures · filed Aug 2019 · $65M raise

Turnstone BiologicsBoard seat

via Versant Ventures · filed Jan 2019 · $42.1M raise

Mistral TherapeuticsBoard seat

via Versant Ventures · filed Jun 2018 · $59.3M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Investor

BorealisbioChinook TherapeuticsGraphite BioLaguna PharmaceuticalsRayze Bio Santa Ana BioTentarix Biotherapeutics

Sources: SEC Form D filings · curated public sources.

Colleagues at Versant Ventures

Alex Mayweg

Managing Director at Versant Ventures

Alicia Levey

Venture Partner at Versant Ventures

Andrew Jefferson

Operating Partner at Versant Ventures

Ariel Kantor

Principal at Versant Ventures

Barbara Lubash

Managing Director at Versant Ventures

Beckie Robertson

Venture Advisor at Intuitive Ventures

Brad Bolzon

Chairman, Managing Director at Versant Ventures

Brian Atwood

Managing Director at Versant Ventures

Frequently asked questions

Who is Jerel Davis?: Jerel Davis is a PhD-trained life scientist and Vancouver-based investor who builds biotechs from scratch via pharma partnerships—co-founding BlueRock with Bayer ($225M) and designing ventures with acquirers in mind.
Where does Jerel Davis work?: Jerel Davis is Managing Director at Versant Ventures and Board director at Firefly Bio, Inc. and Board director at Santa Ana Bio and Board director at Rayze Bio.
What does Jerel Davis invest in?: Jerel Davis invests in Biotech, Healthtech, Medical Devices.
What check size does Jerel Davis write?: Jerel Davis typically writes checks of $100K – $5M.
What boards does Jerel Davis sit on?: Jerel Davis holds tracked board seats at Chinook Therapeutics U.S, Firefly Bio, Inc., Graphite Bio, Inc., Mistral Therapeutics, Turnstone Biologics, Ventus Therapeutics.
What companies has Jerel Davis invested in?: Investments tracked here include Borealisbio, Chinook Therapeutics, Firefly Bio, Inc., Graphite Bio, Laguna Pharmaceuticals, Rayze Bio, Santa Ana Bio, Tentarix Biotherapeutics, Turnstone Biologics, Ventus Therapeutics.
Where did Jerel Davis go to school?: Jerel Davis studied at Stanford University (PhD, Population genetics and genomics); Pepperdine University (BS, Mathematics and Biology).